Biotech & Pharma

City Therapeutics Pursues 'Next Generation of RNAi'

30 sec read12 views0 listens

City Therapeutics, founded by RNAi pioneer John Maraganore, is developing a new class of smaller RNA molecules called cityRNAs that can penetrate tissues unreachable by traditional siRNA therapies. This advancement could lead to more effective treatments for diseases affecting various organs including the CNS and eye, marking a significant step forward in RNA-based medicine. Content creators should focus on how innovations like cityRNAs expand therapeutic possibilities beyond current limitations of existing RNAi technologies.

Read the full article at Genetic Engineering News

Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.

Ali NematiBlogUI.author_articles

BlogUI.view_profile

You Might Like

GitHub Trending3 hours ago34 sec read

bilawalsidhu/gods-eye-view — A spy satellite simulator in your browser, except the data is real. Live open so

8,746 stars | 1,906 forks | JavaScript A spy satellite simulator in your browser, except the data is real. Live open source spatial intelligence on a photorealistic 3D globe. What it does God's Eye View is a real-time, photorealistic 3D globe simulat...

Ali Nemati

Startups & VC4 hours ago27 sec read

The case for hybrid microfinance: Combining AI with social accountability

AI-driven microfinance products in Indonesia are using advanced data analytics to streamline lending processes, offering higher approval rates and lower origination costs compared to traditional methods. However, these systems risk undermining the so...

Ali Nemati

Startups & VC4 hours ago23 sec read

Language was never the problem: Inside SEA's real AI adoption gap

Kai Yong Kang, a partner at GenAI Fund, argues that the primary barrier to AI adoption in Southeast Asia is not language but enterprise trust and secure scalability. This shift highlights the need for deeper localisation efforts beyond mere translati...

Ali Nemati